Bio-Techne
JP Morgan Healthcare Conference, Day 3: Invitae, Bio-Rad, Bio-Techne, Opko
On the penultimate day of the conference, Invitae provided color on its recent decisions to pull out of certain businesses, while Bio-Rad talked about its clinical plans.
Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay
The project will leverage Asuragen's long-range PCR and Oxford Nanopore's sequencing capabilities to develop a sequencing workflow for carrier screening.
In Brief This Week: PerkinElmer, Hologic, Quest Diagnostics, Natera, More
News items for the week of Nov. 14, 2022.
Bio-Techne Fiscal Q1 Revenues Rise 5 Percent
The firm saw 15 percent growth in its Diagnostics and Genomics segment and 1 percent growth in its Protein Sciences business.
Bio-Techne Files UK Patent Infringement Suit Against Molecular Instruments
The suit involves two patents related to Bio-Techne subsidiary Advanced Cell Diagnostics' RNAscope in situ hybridization technology.
Aug 4, 2022
Aug 4, 2022
Bio-Techne Q4 Revenues Climb 11 Percent
May 4, 2022
Bio-Techne Fiscal Q3 Revenues Rise 19 Percent
Feb 1, 2022
Bio-Techne Fiscal Q2 Revenues Rise 20 Percent
Jan 4, 2022
360Dx Index Rises 20 Percent in 2021
Nov 2, 2021
Bio-Techne Fiscal Q1 Revenues Rise 26 Percent
Aug 5, 2021